Cargando…

T Cells in Atherosclerosis in Ldlr−/− and Apoe−/− Mice

Atherosclerosis is the underlying basis for most cardiovascular diseases. It is a chronic inflammation affecting the arterial intima and is promoted by hypercholesterolemia. Cells of both the innate and adaptive immune systems contribute to this inflammation with macrophages and T cells being the mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Getz, Godfrey S., Reardon, Catherine A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404748/ https://www.ncbi.nlm.nih.gov/pubmed/30854522 http://dx.doi.org/10.29245/2578-3009/2018/3.1144

Ejemplares similares

Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr(−/−) Mice
por: Subramanian, Savitha, et al.
Publicado: (2018)

Serum Amyloid A Facilitates Early Lesion Development in Ldlr(−/−) Mice
por: Krishack, Paulette A, et al.
Publicado: (2015)

The Apolipoprotein-AI Mimetic Peptide L4F at a Modest Dose Does Not Attenuate Weight Gain, Inflammation, or Atherosclerosis in LDLR-Null Mice
por: Averill, Michelle M., et al.
Publicado: (2014)

Apolipoprotein A-I and A-I mimetic peptides: a role in atherosclerosis
por: Getz, Godfrey S, et al.
Publicado: (2011)

Atherogenesis in Apoe(−/−) and Ldlr(−/−) Mice with a Genetically Resistant Background
por: Torikai, Hideyuki, et al.
Publicado: (2023)

Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR(−/−) Mouse Strain
por: Lantos, Ildikó, et al.
Publicado: (2018)

CD1d Selectively Down Regulates the Expression of the Oxidized Phospholipid-Specific E06 IgM Natural Antibody in Ldlr(−/−) Mice
por: Biswas, Tapan K., et al.
Publicado: (2020)

The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE(−/−) and LDLr(−/−) Mice by a Mechanism That Includes Inflammatory Pathways
por: Rakipovski, Günaj, et al.
Publicado: (2018)

Poloxamer 407 Induces Hypertriglyceridemia but Decreases Atherosclerosis in Ldlr(−/−) Mice
por: Peng, Xueying, et al.
Publicado: (2022)

Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice
por: Park, Kyung-Yeon, et al.
Publicado: (2016)

Invariant Natural Killer T-Cells and Total CD1d Restricted Cells Differentially Influence Lipid Metabolism and Atherosclerosis in Low Density Receptor Deficient Mice
por: VanderLaan, Paul A., et al.
Publicado: (2019)

Different Susceptibilities between Apoe- and Ldlr-Deficient Mice to Inflammation-Associated Colorectal Carcinogenesis
por: Tanaka, Takuji, et al.
Publicado: (2016)

Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr(−/−) mice
por: Rajamoorthi, Ananthi, et al.
Publicado: (2018)

Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice
por: Babaev, Vladimir R., et al.
Publicado: (2014)

Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice
por: Zhu, Lin, et al.
Publicado: (2014)

Uptake of (68)gallium in atherosclerotic plaques in LDLR(-/-)ApoB(100/100 )mice
por: Silvola, Johanna MU, et al.
Publicado: (2011)

Tanshinone IIA alleviates atherosclerosis in LDLR(−/−) mice by regulating efferocytosis of macrophages
por: Wang, Jiarou, et al.
Publicado: (2023)

Effects of Long-term Thrombin Inhibition (Dabigatran Etexilate) on Spontaneous Thrombolytic Activity during the Progression of Atherosclerosis in ApoE(−/−)–LDLR(−/−) Double-Knockout Mice
por: Sanda, Tomohide, et al.
Publicado: (2020)

Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms
por: Yang, Yanfang, et al.
Publicado: (2023)

Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr(−/−) mice
por: Tao, Huan, et al.
Publicado: (2020)

Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice
por: Bisgaard, Line S., et al.
Publicado: (2016)

Dysregulated CD4(+) T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr(−/−) mice
por: Wilhelm, Ashley J, et al.
Publicado: (2015)

ApoB100/LDLR-/- Hypercholesterolaemic Mice as a Model for Mild Cognitive Impairment and Neuronal Damage
por: Ramírez, Carlos, et al.
Publicado: (2011)

Western Diet Decreases Hepatic Drug Metabolism in Male LDLr(−/−)ApoB(100/100) Mice
por: Koponen, Markus, et al.
Publicado: (2023)

Subcutaneous Administration of Apolipoprotein J-Derived Mimetic Peptide d-[113–122]apoJ Improves LDL and HDL Function and Prevents Atherosclerosis in LDLR-KO Mice
por: Rivas-Urbina, Andrea, et al.
Publicado: (2020)

CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice
por: Riopel, Matthew, et al.
Publicado: (2018)

Exercise capacity and cardiac hemodynamic response in female ApoE/LDLR(−/−) mice: a paradox of preserved V’O(2max) and exercise capacity despite coronary atherosclerosis
por: Wojewoda, M., et al.
Publicado: (2016)

The secretome of liver X receptor agonist‐treated early outgrowth cells decreases atherosclerosis in Ldlr−/− mice
por: Rasheed, Adil, et al.
Publicado: (2020)

APOE and LDLR Gene Polymorphisms and Dyslipidemia Tracking. Rio de Janeiro Study
por: de Freitas, Rossana Ghessa Andrade, et al.
Publicado: (2015)

Thalidomide influences atherogenesis in aortas of ApoE(−/−)/LDLR(−/−) double knockout mice: a nano-CT study
por: Kampschulte, Marian, et al.
Publicado: (2014)

Impact of atherosclerotic disease on cerebral microvasculature and tissue oxygenation in awake LDLR−/−hApoB+/+ transgenic mice
por: Lu, Yuankang, et al.
Publicado: (2019)

Apoprotein E and Reverse Cholesterol Transport
por: Getz, Godfrey S., et al.
Publicado: (2018)

Apoproteins E, A-I, and SAA in Macrophage Pathobiology Related to Atherogenesis
por: Getz, Godfrey S., et al.
Publicado: (2019)

Oxidative Stress and Lipid Accumulation Augments Cell Death in LDLR-Deficient RPE Cells and Ldlr (−/−) Mice
por: Sreekumar, Parameswaran Gangadharan, et al.
Publicado: (2022)

Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr (−/−) Mice Compared to Nondiabetic LDLr (−/−) Mice
por: Engelbertsen, Daniel, et al.
Publicado: (2012)

PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2021)

Loss of Rictor in Monocyte/Macrophages Suppresses Their Proliferation and Viability Reducing Atherosclerosis in LDLR Null Mice
por: Babaev, Vladimir R., et al.
Publicado: (2018)

The Cordyceps militaris-Derived Polysaccharide CM1 Alleviates Atherosclerosis in LDLR((-/-)) Mice by Improving Hyperlipidemia
por: Yin, Fan, et al.
Publicado: (2021)

The Effects of Selective Hematopoietic Expression of Human IL-37 on Systemic Inflammation and Atherosclerosis in LDLr-Deficient Mice
por: Hoeke, Geerte, et al.
Publicado: (2017)

Targeted Disruption of LDLR Causes Hypercholesterolemia and Atherosclerosis in Yucatan Miniature Pigs
por: Davis, Bryan T., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_0ehjvr8h331v7u41d1nmpml86h